SNY Reports 4Q09 Annualized Lovenox Sales of $4.2B, $2.4B in US
[Sanofi’s reporting currency is the Euro, but the growth rates shown below are in local currencies. Tallying growth in local currencies is a way to track the change in volume and price irrespective of exchange rates. The figures below are annualized, i.e. they are 4x the reported 4Q09 numbers.]
Worldwide Lovenox sales rose 8% year-over-year to an annualized rate of €3.02B, which is $4.2B at the current exchange rate.
US Lovenox sales rose 9% year-over-year to an annualized rate of €1.77B, which is $2.4B at the current exchange rate.
The breakdown of annualized 4Q09 Lovenox sales by geography is as follows; growth rates are year-over-year in local currencies:
US: €1.77B (59% of total), 9% growth EU: €908M (30% of total), 7% growth RoW: €336M (11% of total), 6% growth === Total: €3.02B, 8% growth
Market Data 
Markets 
AI
